1. Home
  2. WORX vs GRI Comparison

WORX vs GRI Comparison

Compare WORX & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCWorx Corp.

WORX

SCWorx Corp.

HOLD

Current Price

$0.12

Market Cap

2.3M

ML Signal

HOLD

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

N/A

Current Price

$2.30

Market Cap

1.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WORX
GRI
Founded
N/A
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
1.9M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
WORX
GRI
Price
$0.12
$2.30
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$160.00
AVG Volume (30 Days)
3.5M
37.3K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
79.79
N/A
EPS
N/A
N/A
Revenue
$2,989,599.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.18
52 Week High
$1.37
$11.12

Technical Indicators

Market Signals
Indicator
WORX
GRI
Relative Strength Index (RSI) 35.66 44.99
Support Level $0.11 $2.18
Resistance Level $0.17 $2.73
Average True Range (ATR) 0.02 0.22
MACD 0.00 -0.06
Stochastic Oscillator 16.32 0.00

Price Performance

Historical Comparison
WORX
GRI

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: